See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Chevron Corporation (CVX) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chevron Corporation (CVX) - free report >>
Image: Bigstock
New Strong Buy Stocks for July 13th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
· Carlisle Companies, Inc. (CSL - Free Report) operates as a diversified manufacturing company in the United States and internationally. The Zacks Consensus Estimate for its current year earnings has advanced by 0.3% over the last 30 days.
· Carter's, Inc. (CRI - Free Report) design, source, and market branded childrenswear under the Carters, Child of Mine, Just One You, Precious Firsts, OshKosh and other brands. The Zacks Consensus Estimate for its current year earnings has gained by 0.1% over the last 30 days.
· Chevron Corporation (CVX - Free Report) engages in integrated energy, chemicals and petroleum operations worldwide. It has seen the Zacks Consensus Estimate for its current year earnings jump 8.9% over the last 30 days.
· Diamond Resorts International Inc operates in the hospitality and vacation ownership industry in the continental United States, Hawaii, Canada, Mexico, the Caribbean, Central America, South America, Europe, Asia, Australia, New Zealand and Africa. The Zacks Consensus Estimate revision for its current year earnings was a positive 0.2% over the last 30 days.
· Loxo Oncology Inc develops and sells medicines for patients with genetically defined cancers primarily in the United States. The Zacks Consensus Estimate for its current year earnings has increased 3.4% over the last 30 days.
View the entire Zacks Rank #1 List